Skip to content

BENU

Active
Public limited companyfounded 1989active for 37 yearsAvenue Pasteur 2, 1300 Wavre, BelgiumKBO/BCE: BE 0436.826.929
Summary

BENU has been active since 1989 and the Belgian Official Gazette contains no insolvency or warning signals. The 2026 annual accounts show equity of €43.1m and a net result of €1.4m. Equity is growing by about 10% per year across the filed financial years. Its solvency ranks better than 67% of 276 sector peers (NACE 47, financial year 2026). The computed 12-month bankruptcy probability is 0.3% (very low).

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
#1 employer in Wavre, Wholesale and retail trade sector112 sites
Size
€172.2mturnover 2026
Staff
370.2 FTE
Equity
€43.1m
Profit
€1.4m
Financial health
88 Excellent Checked score 2026
Bankruptcy probabilitywithin 12 months
0.3%
Structure
Parent
BENU Management · 100%
Board
4 members
Holdings
1
Accounts 67 days early22 of 148 deeds read
Why 88raises riskLiquidity: current ratio 1.39, cash €992,585Sector: Retail trade (NACE 47)lowers riskFounded in 1989Legal form: public limited companyShow the evidence

Checked score

Score 2026
88 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 60% of its sector peers (NACE 47, large)
Financial strength · tick = 2025
Average
Solvency 76-11
equity 51.2% of total assets
Liquidity 28-6
short-term debt 48.2% · cash 1.2%
Profitability 57=
return on assets 1.7%
Bankruptcy probability, 12 months
0.3% Very low
0%0.5%1.5%4%10%≥ 25%

About 3 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.4% (83 companies, NACE 47, large)
Last 24 months 11-2024: 0.2% 12-2024: 0.2%● unchanged vs 11-2024 01-2025: 0.2%● unchanged vs 12-2024 02-2025: 0.2%● unchanged vs 01-2025 03-2025: 0.2%● unchanged vs 02-2025lowest value 04-2025: 0.2%● unchanged vs 03-2025 05-2025: 0.2%● unchanged vs 04-2025 06-2025: 0.2%● unchanged vs 05-2025 07-2025: 0.2%● unchanged vs 06-2025 08-2025: 0.2%● unchanged vs 07-2025 09-2025: 0.2%● unchanged vs 08-2025 10-2025: 0.2%● unchanged vs 09-2025 11-2025: 0.2%● unchanged vs 10-2025 12-2025: 0.2%● unchanged vs 11-2025 01-2026: 0.2%● unchanged vs 12-2025 02-2026: 0.2%● unchanged vs 01-2026 03-2026: 0.2%● unchanged vs 02-2026 04-2026: 0.2%● unchanged vs 03-2026 05-2026: 0.2%● unchanged vs 04-2026 06-2026: 0.2%● unchanged vs 05-2026 07-2026: 0.3%▲ +0.1 percentage points vs 06-2026highest value 08-2026: 0.3%● unchanged vs 07-2026highest value 09-2026: 0.3%● unchanged vs 08-2026highest value 10-2026: 0.3%● unchanged vs 09-2026highest value
Credit of up to €3,750,000 on 30-day terms is acceptable
Liquidity tight (current ratio 1.39, compared with 1.51 in 2025; short-term debt: 48.2% and cash: 1.2% of total assets), and 48.8% of the assets are financed with debt.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, large): better than 84% on solvency, 46% on liquidity, 43% on profitability and 65% on growth.

The bankruptcy probability was computed on 08-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
−lowers risk+raises risk○neutral
raises risk · Liquidity: current ratio 1.39, cash €992,585
NBB · annual accounts
lowers risk · Founded in 1989
How long the company has existed counts in the probability; how much depends on the rest of its profile.
KBO
raises risk · Sector: Retail trade (NACE 47)
KBO
lowers risk · Legal form: public limited company
KBO
neutral · Latest accounts filed on time
The financial year that closed on 31-01-2026 was due by 31-08-2026 and was filed on 25-06-2026, 67 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2026
67 days early
2025
52 days early
2024
53 days early
2023
28 days early
2022
31 days early
2021
44 days early
2020
9 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 41 days before the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-01-2027 and is due by 31-08-2027. Nothing is late today. The company usually files around 10 July (3 of the last 3 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
09-10-2026 today31-01-2027 year end31-08-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Capital & shares · Amendment of…Merger · Capital increase ·…
  2. Capital & shares · RestructuringAccounting effect · Capital increase…
  3. Reappointments: An Marin, Arnaud Berken and…Gazette deed

Key points

  • Positive: Employer in Wavre, Wholesale and retail trade sectorin the Checked rankings #1 View
  • 5 restructurings since 2025latest: merger with APOTEEK KELLES 5 View
  • Positive: Filed on time since financial year 2019accounts within the deadline every year 8 years View
  • Positive: 8 profitable years in a rowprofit 2026: €1.4m 8 years View
  • Controlled by BENU Managementultimately: PHOENIX Pharmahandel GmbH &… 100% View

By topic

Financials

Financial year
2026
Turnover
€172.2m
Profit
€1.4m
Solvency
51.2%
Turnover▲ 3.5%
Net result
20192026
Go to Financials

Board & ownership

Board
4 members
Parent
BENU Management · 100%
  • An MarinDirector
  • Armaud BerkenDirector
  • Arnaud BerkenDirector
  • Philippe LacroixDirector
Go to Board & ownership

Network & group

Group
PHOENIX Pharmahandel GmbH &…
Subsidiaries
1
Mergers and contributions
6

1 subsidiary

Go to Network & group

Timeline

Events
52
Since
1990
Next accounts
by 31-08-2027
  1. 10-07-2026Capital & shares · Restructuring
  2. 25-06-2026Annual accounts filed
  3. 05-05-2026Miscellaneous
Go to Timeline

Company details

Sites
112
Legal form
Public limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
08-02-1989
Year ends
31-01
Peppol
Reachable for e-invoices
Go to Company details

Articles of association

Provisions read
7
Purpose
La gestion administrative et commerciale d'une ou plusieurs pharmacies exploitées sous la…
Go to Articles of association

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.